Justin E Swartz
Overview
Explore the profile of Justin E Swartz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
353
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smits H, Swartz J, Philippens M, de Bree R, Kaanders J, Koppes S, et al.
J Pathol Inform
. 2023 Feb;
14:100198.
PMID: 36818021
Objectives: This study aimed to validate a digital image analysis (DIA) workflow for automatic positive cell detection and positive region delineation for immunohistochemical hypoxia markers with a nuclear (hypoxia-inducible factor...
2.
Swartz J, Smits H, Philippens M, de Bree R, Kaanders J, Willems S
Oral Oncol
. 2022 Apr;
128:105862.
PMID: 35447566
Objective: Tumor hypoxia results in worse local control and patient survival. We performed a digital, single-cell-based analysis to compare two biomarkers for hypoxia (hypoxia-inducible factor 1-alpha [HIF-1α] and pimonidazole [PIMO])...
3.
van Heusden H, Swartz J, Chargi N, de Jong P, van Baal M, Wegner I, et al.
Eur J Radiol
. 2021 Aug;
142:109879.
PMID: 34343845
Background: Skeletal muscle mass (SMM) determined on computed tomography (CT) is emerging as a novel imaging biomarker. Cross-sectional area (CSA) of SMM at the level of the third lumbar vertebra...
4.
de Bree R, Swartz J, Bril S, Chargi N, Wegner I, Smid E
Radiother Oncol
. 2021 Jun;
161:72-73.
PMID: 34107294
No abstract available.
5.
Swartz J, Wegner I, Noorlag R, van Kempen P, van Es R, de Bree R, et al.
Head Neck
. 2020 Nov;
43(3):745-756.
PMID: 33155375
Background: Hypoxia is a negative prognostic factor in head and neck squamous cell carcinomas. Under hypoxia, the hypoxia-inducible factor (HIF)-1a transcription factor is overexpressed. We investigated whether there were site...
6.
Swartz J, Driessen J, van Kempen P, de Bree R, Janssen L, Pameijer F, et al.
Oral Oncol
. 2018 Jan;
77:9-15.
PMID: 29362130
Objectives: Diffusion weighted imaging (DWI) is a frequently performed MRI sequence in cancer patients. While previous studies have shown the clinical value of the apparent diffusion coefficient (ADC) for response...
7.
Wendrich A, Swartz J, Bril S, Wegner I, de Graeff A, Smid E, et al.
Oral Oncol
. 2017 Jul;
71:26-33.
PMID: 28688687
Objectives: Low skeletal muscle mass (SMM) or sarcopenia is emerging as an adverse prognostic factor for chemotherapy dose-limiting toxicity (CLDT) and survival in cancer patients. Our aim was to determine...
8.
Swartz J, Pothen A, Wegner I, Smid E, Swart K, de Bree R, et al.
Oral Oncol
. 2016 Nov;
62:28-33.
PMID: 27865369
Objectives: Patients with head and neck cancer (HNC) have a higher risk of malnutrition and sarcopenia, which is associated with adverse clinical outcome. As abdominal CT-imaging is often used to...
9.
van Kempen P, Noorlag R, Swartz J, Bovenschen N, Braunius W, Vermeulen J, et al.
Cancer Immunol Immunother
. 2016 Mar;
65(5):575-85.
PMID: 26993499
Objectives: Patients with human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinomas (OPSCCs) have an improved prognosis compared to HPV-negative OPSCCs. Several theories have been proposed to explain this relatively good prognosis....
10.
Koole K, van Kempen P, Swartz J, Peeters T, van Diest P, Koole R, et al.
Cancer Med
. 2015 Dec;
5(2):275-84.
PMID: 26711175
Fibroblast growth factor receptor 3 (FGFR3) is a member of the fibroblast growth factor receptor tyrosine kinase family. It has been identified as a promising therapeutic target in multiple types...